HSAP’s “Prevention, Screening, Diagnosis, Treatment, And Care” Series Of AD Equipment Debuts At A Health Management Event in Wuhan; Its Full-Chain Closed-Loop Model Draws Significant Industry Attention

HSAP's "Prevention, Screening, Diagnosis, Treatment, and Care" Series of AD Equipment Debuts at a Health Management Event in Wuhan; Its Full-Chain Closed-Loop Model Draws Significant Industry Attention

From March 20 to 22, the 2026 Academic Annual Conference, the 5th Health Management Innovation and Development Conference, and the 4th Symposium on the Development of Health Management Institutions in County-Level Hospitals, organized by the Health Management Institution Development Branch of the China Health Management Association, were grandly held in Wuhan, Hubei.

This conference focuses on core topics such as innovative development in the health management industry, the upgrading of county-level medical and health services, and the prevention and control of chronic diseases and cognitive health issues among the elderly. It brings together top experts in the field of health management, heads of medical institutions, and industry professionals from across the country to explore new paths for industry development. HSAP, a leading domestic enterprise in the cognitive health management sector, was invited to make a significant appearance at the event. The company showcased its proprietary "screening + diagnosis + training + treatment" closed-loop management system for cognitive impairment, which garnered widespread attention and high acclaim from industry experts and attendees alike thanks to its cutting-edge technology and innovative solutions.

As China's population continues to age at an accelerating pace, cognitive disorders such as Alzheimer's disease have become major public health issues that impact the quality of life for the elderly and place a growing burden on families and society. Addressing the challenges of early screening, diagnosis, and intervention for cognitive disorders has become a key priority for the health management industry and the elderly care sector.

HSAP is firmly grounded in the critical needs of cognitive health among China's elderly population. With years of deep expertise in the R&D and technological innovation of cognitive health management devices, the company leverages five core technologies-bioimpedance, bionic pulse magnetic resonance, brain-computer interfaces, neurostimulation, and artificial intelligence-to independently develop a full range of professional medical equipment. This approach completely overcomes the limitations of fragmented diagnosis and treatment and one-dimensional interventions in traditional cognitive disorder management, innovatively establishing a comprehensive, closed-loop "prevention, screening, diagnosis, treatment, and care," and has created an integrated solution spanning early prevention, precise screening, professional diagnosis, targeted treatment, and comprehensive wellness care. We are fully committed to building a robust defense for the cognitive health of hundreds of millions of elderly people and supporting the high-quality, sustainable development of China's elderly care and wellness sector.

During the keynote session of the conference, Chu Xinmin, Director of the Health Management Center at the First Affiliated Hospital of the University of Science and Technology of China, delivered a special report titled "Building a New System for the Prevention and Treatment of Alzheimer's Disease Based on Brain-Computer Interface Technology." He provided an in-depth analysis of the current state of clinical prevention and treatment for Alzheimer's disease, as well as industry pain points and development bottlenecks, He provided a detailed interpretation of relevant national prevention and treatment policies and industry expert consensus, emphasizing the core application value of Huisi Anpu's brain-computer interface technology throughout the entire process of early screening, precise diagnosis, rehabilitation training, and intervention therapy for Alzheimer's disease, thereby charting a course for technological upgrades and system improvements in the cognitive health management industry.

For a long time, primary care settings have faced common industry challenges, including insufficient resources for cognitive impairment screening, a shortage of specialized personnel, subjective and incomplete traditional scale assessments, and high rates of missed or misdiagnoses. These issues have resulted in a large number of patients with mild cognitive impairment going undetected, causing them to miss the optimal window for intervention. To address this core challenge, HSAP leverages the deep capabilities of artificial intelligence to innovatively introduce a "AI + Authoritative Scales + EEG" multimodal precision initial screening model, completely revolutionizing traditional screening methods.

For screening and diagnosis, HSAP has launched the ADDS Cognitive Impairment Screening System. Through user-friendly voice and image-based interactions, it effortlessly conducts cognitive function screening and assessment for patients. The entire process is non-invasive, painless, and tailored to the operational habits of the elderly; Simultaneously, leveraging AI deep learning algorithms, the system accurately extracts key EEG parameters such as alpha and beta waves for multidimensional in-depth analysis and quantitative assessment. It can rapidly and precisely distinguish between individuals with normal cognition, mild cognitive impairment, and those suspected of having Alzheimer's disease. The screening results are objective, scientific, and efficient, providing a solid and precise basis for subsequent personalized intervention and treatment. This series of devices not only meets the needs of tertiary hospitals for refined diagnosis and treatment but also perfectly aligns with the large-scale, inclusive screening scenarios of primary care institutions such as county hospitals and community health service centers, effectively promoting the decentralization of cognitive impairment prevention and treatment.

It is clinically recognized that Alzheimer's disease is "incurable but effectively manageable." Early, standardized, and targeted rehabilitation interventions are key to slowing disease progression and improving patients' quality of life. Huisanpu firmly adheres to this clinical treatment principle. Leveraging non-invasive brain-computer interface (BCI) technology as its core foundation, the company has developed a range of non-invasive, safe, and highly effective cognitive rehabilitation devices. This has resulted in a highly targeted cognitive impairment rehabilitation system, filling a technological gap in this field within China.

ADTS Memory Impairment Training Device: By deeply integrating artificial intelligence with non-invasive brain-computer interface technology, this device overcomes the limitations of traditional rehabilitation training-which is often passive and monotonous. Through EEG-driven intelligent control, it directs the entire process of professional, intelligent rehabilitation game training, effectively activating neurons in the cerebral cortex. This significantly enhances brain focus, neural activity complexity, and apparent entropy, continuously strengthening brain function and addressing memory decline. It is suitable for daily rehabilitation training for individuals with mild cognitive impairment and those in the early stages of Alzheimer's disease.

ADMS Cognitive Neurostimulation System: Utilizing an innovative approach that combines multisensory stimulation with physical modulation, this system employs synchronized stimulation across three sensory dimensions-visual, auditory, and tactile-in conjunction with dual technologies: photobiomodulation of brain regions and ultra-low-frequency whole-body magnetic field stimulation. This approach induces broader and more intense gamma oscillations in the brain, precisely targeting Alzheimer's-related deep brain regions such as the hippocampus, the insula, and the amygdala-all deep brain regions associated with Alzheimer's disease. This effectively slows the progression of neurodegenerative conditions, alleviates dementia-related symptoms, and enhances patients' cognitive abilities and activities of daily living, all without any invasive procedures or side effects.

Throughout the conference, the HSAP booth remained a bustling hub, attracting numerous top industry experts and representatives from medical institutions who stopped by to tour the exhibition, experience the equipment, and discuss collaboration opportunities. During conference breaks, Bai Shuzhong-founder of the Health Management Branch of the Chinese Medical Association, founding chairman of the China Health Promotion Foundation, and former director of the Health Department of the General Logistics Department of the People's Liberation Army- Han Ping, former Vice President of Xiaotangshan Hospital and current Chairperson of the China Health Promotion Foundation, and other senior industry experts made a special visit to the HSAP booth. They conducted a detailed review of the technical principles, clinical applications, and practical outcomes of the series of cognitive health management devices, and fully affirmed HSAP's deep commitment to the field of cognitive health and its dedication to independent innovation.

Xu Sanping, Chief Physician, Associate Professor, and Master's Supervisor in the Department of Gastroenterology at Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology; Chu Xi, Director of the Health Management Department, Chief Physician, Associate Professor, and Doctor of Medicine at Xuanwu Hospital of Capital Medical University; Lin Weihong, Director of the Healthcare Center at the First Affiliated Hospital of Wenzhou Medical University, and other frontline clinical experts personally experienced the device's screening and intervention processes on-site. They engaged in in-depth discussions with the HSAP team regarding the device's clinical applicability, implementation scenarios at the grassroots level, and technical upgrades and optimizations, providing valuable guidance for the device's future iterations and industry promotion.

The debut at this major health management event in Wuhan not only fully demonstrated HSAP's technical capabilities and innovative achievements in the field of cognitive health management but also highlighted the leading advantages of its full-chain, closed-loop management model within the industry.

An integrated system for the "prevention, screening, diagnosis, treatment, and care," fundamentally transforms the traditional passive approach to cognitive impairment. We are fully committed to shifting the focus of Alzheimer's disease prevention and treatment to earlier stages, achieving a fundamental shift from "passive treatment" to "active prevention and early intervention." This initiative aims to help solve the challenges of cognitive health management in the elderly, enabling more seniors to avoid the distress of "memory loss" and safeguard a happy life in their golden years.

In the future, HSAP will remain committed to its original mission of independent innovation, deepen its expertise in the field of cognitive health management, and continuously optimize its technology and equipment systems. We will accelerate the implementation and widespread adoption of our end-to-end solutions across medical institutions, healthcare and wellness facilities, and grassroots communities. By leveraging cutting-edge technology to empower China's cognitive health prevention and control efforts, we will make a solid contribution to actively addressing population aging and advancing the "Healthy China" initiative.